NUVL
NUVL
NASDAQ · Biotechnology

Nuvalent Inc-A

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$123.59
+0.15 (+0.12%)
As of Jun 24, 8:00 PM ET ·
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 23 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target -73.1% upside
Low Target $20.12
Average Target $33.28
High Target $44.46
Current Price $123.59
Current
$123.59
Target
$33.28
$20.12 $33.28 avg $44.46
Scenario Analysis
Bear Case
$20.12
-83.7%
Low target
Base Case
$33.28
-73.1%
Avg target
Bull Case
$44.46
+-64.0%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$123.62
0.0% from high
52-Week Low
$71.13
+73.8% from low
50-Day SMA
$103.76
+19.1% vs SMA
200-Day SMA
$88.57
+39.5% vs SMA
RSI (14)
53.7
Neutral
Target vs 52W High
$33.28
-73.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +188.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -8.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.9%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.0%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.4%